Published in Biochem J on May 01, 2006
Agouti protein, mahogunin, and attractin in pheomelanogenesis and melanoblast-like alteration of melanocytes: a cAMP-independent pathway. Pigment Cell Melanoma Res (2009) 1.02
Suppression of melanin production by expression of HSP70. J Biol Chem (2010) 0.96
Inhibition of melanogenesis by gallic acid: possible involvement of the PI3K/Akt, MEK/ERK and Wnt/β-catenin signaling pathways in B16F10 cells. Int J Mol Sci (2013) 0.92
Signaling Pathways in Melanogenesis. Int J Mol Sci (2016) 0.87
Reduced MiR-675 in exosome in H19 RNA-related melanogenesis via MITF as a direct target. J Invest Dermatol (2013) 0.87
Anti-melanogenic property of geoditin A in murine B16 melanoma cells. Mar Drugs (2012) 0.82
Ion transport in pigmentation. Arch Biochem Biophys (2014) 0.81
Role of BMP-4 and Its Signaling Pathways in Cultured Human Melanocytes. Int J Cell Biol (2009) 0.80
Cornus officinalis Methanol Extract Upregulates Melanogenesis in Melan-a Cells. Toxicol Res (2015) 0.78
Metformin: a potential drug to treat hyperpigmentation disorders. J Invest Dermatol (2014) 0.76
Enhanced bleaching treatment: opportunities for immune-assisted melanocyte suicide in vitiligo. Exp Dermatol (2014) 0.75
Transcriptional mechanism of vascular endothelial growth factor-induced expression of protein kinase CβII in chronic lymphocytic leukaemia cells. Sci Rep (2017) 0.75
Angiotensin II stimulates melanogenesis via the protein kinase C pathway. Exp Ther Med (2015) 0.75
Association detection between genetic variants in the microRNA binding sites of toll-like receptors signaling pathway genes and bladder cancer susceptibility. Int J Clin Exp Pathol (2014) 0.75
Quercetin-3-O-β-d-glucopyranosyl-(1 → 6)-β-d-glucopyranoside suppresses melanin synthesis by augmenting p38 MAPK and CREB signaling pathways and subsequent cAMP down-regulation in murine melanoma cells. Saudi J Biol Sci (2015) 0.75
Anti-Melanogenic Effect of Oenothera laciniata Methanol Extract in Melan-a Cells. Toxicol Res (2017) 0.75
Trends in Regenerative Medicine: Repigmentation in Vitiligo Through Melanocyte Stem Cell Mobilization. Med Res Rev (2016) 0.75
The functional property of royal jelly 10-hydroxy-2-decenoic acid as a melanogenesis inhibitor. BMC Complement Altern Med (2017) 0.75
Protein serine/threonine kinases. Annu Rev Biochem (1987) 8.42
Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability. Cell (2002) 3.72
Waardenburg syndrome type 2 caused by mutations in the human microphthalmia (MITF) gene. Nat Genet (1994) 2.99
Mitf from neural crest to melanoma: signal transduction and transcription in the melanocyte lineage. Genes Dev (2000) 2.43
Microphthalmia gene product as a signal transducer in cAMP-induced differentiation of melanocytes. J Cell Biol (1998) 2.20
Microphthalamia-associated transcription factor: a critical regulator of pigment cell development and survival. Oncogene (2003) 2.19
The melanocortin receptors: agonists, antagonists, and the hormonal control of pigmentation. Recent Prog Horm Res (1996) 1.94
Effect of alpha- and betamelanocyte stimulating hormones on the skin colour of man. Nature (1961) 1.80
Regulation of tyrosinase in human melanocytes grown in culture. J Cell Biol (1983) 1.71
Human melanogenesis is stimulated by diacylglycerol. J Invest Dermatol (1989) 1.71
Control of phenotypic expression of cultured melanoma cells by melanocyte stimulating hormones. Nat New Biol (1973) 1.60
Functional analysis of microphthalmia-associated transcription factor in pigment cell-specific transcription of the human tyrosinase family genes. J Biol Chem (1997) 1.59
Ectopic expression of MITF, a gene for Waardenburg syndrome type 2, converts fibroblasts to cells with melanocyte characteristics. Nat Genet (1996) 1.58
Tyrosine hydroxylation catalyzed by mammalian tyrosinase: an improved method of assay. Biochem Biophys Res Commun (1964) 1.56
Topically applied diacylglycerols increase pigmentation in guinea pig skin. J Invest Dermatol (1995) 1.52
Mitogenic and melanogenic stimulation of normal human melanocytes by melanotropic peptides. Proc Natl Acad Sci U S A (1995) 1.42
Molecular biology of pigment cells. Molecular controls in mammalian pigmentation. Yale J Biol Med (1973) 1.39
Melanocyte-stimulating hormone promotes activation of pre-existing tyrosinase molecules in Cloudman S91 melanoma cells. Nature (1975) 1.36
Opioid receptor signalling mechanisms. Clin Exp Pharmacol Physiol (1999) 1.35
Genomic analysis of the Microphthalmia locus and identification of the MITF-J/Mitf-J isoform. Gene (2005) 1.35
alpha-Melanocyte-stimulating hormone signaling regulates expression of microphthalmia, a gene deficient in Waardenburg syndrome. J Biol Chem (1998) 1.34
Identification of a novel isoform of microphthalmia-associated transcription factor that is enriched in retinal pigment epithelium. Biochem Biophys Res Commun (1998) 1.30
Microphthalmia-associated transcription factor (MITF): multiplicity in structure, function, and regulation. J Investig Dermatol Symp Proc (2001) 1.29
Modulation of microphthalmia-associated transcription factor gene expression alters skin pigmentation. J Invest Dermatol (2002) 1.25
Identification of a melanocyte-type promoter of the microphthalmia-associated transcription factor gene. Biochem Biophys Res Commun (1996) 1.24
Factors regulating growth and pigmentation of melanoma cells. J Invest Dermatol (1976) 1.23
The mouse tyrosinase promoter is sufficient for expression in melanocytes and in the pigmented epithelium of the retina. Proc Natl Acad Sci U S A (1991) 1.20
Expression of genes for microphthalmia isoforms, Pax3 and MSG1, in human melanomas. Cell Mol Biol (Noisy-le-grand) (1999) 1.17
Tyrosinase as a marker for transgenic mice. Nucleic Acids Res (1991) 1.14
Carbohydrates act as sorting determinants in ER-associated degradation of tyrosinase. J Cell Sci (2004) 1.14
Microphthalmia-associated transcription factor in the Wnt signaling pathway. Pigment Cell Res (2003) 1.12
Mammalian tyrosinase: biosynthesis, processing, and modulation by melanocyte-stimulating hormone. Proc Natl Acad Sci U S A (1988) 1.09
Tyrosinase activity and abundance in Cloudman melanoma cells. Arch Biochem Biophys (1984) 1.07
Microphthalmia-associated transcription factor (MITF) is required but is not sufficient to induce the expression of melanogenic genes. Pigment Cell Res (2003) 1.07
Alpha-melanocyte-stimulating hormone regulation of tyrosinase in Cloudman S-91 mouse melanoma cell cultures. J Biol Chem (1987) 1.05
Activation of melanoma tyrosinase by a cyclic AMP-dependent protein kinase in a cell-free system. Nature (1977) 1.04
Cloning and functional characterization of a family of receptors for the melanotropic peptides. Ann N Y Acad Sci (1993) 1.01
Molecular cloning of cDNA encoding a novel microphthalmia-associated transcription factor isoform with a distinct amino-terminus. J Biochem (1999) 0.99
Isoforms of mi transcription factor preferentially expressed in cultured mast cells of mice. Biochem Biophys Res Commun (2002) 0.99
The role of RNA and protein synthesis in mediating the action of MSH on mouse melanoma cells. Life Sci (1979) 0.98
Pigment content of cultured human melanocytes does not correlate with tyrosinase message level. Br J Dermatol (1991) 0.98
The beta isoform of protein kinase C stimulates human melanogenesis by activating tyrosinase in pigment cells. J Biol Chem (1993) 0.97
Protein kinase C-beta activates tyrosinase by phosphorylating serine residues in its cytoplasmic domain. J Biol Chem (1999) 0.97
Diagnostic utility of microphthalmia transcription factor in malignant melanoma and other tumors. Adv Anat Pathol (2001) 0.97
Selective down-regulation of tyrosinase family gene TYRP1 by inhibition of the activity of melanocyte transcription factor, MITF. Nucleic Acids Res (2002) 0.95
Mitogenic, melanogenic, and cAMP responses of cultured neonatal human melanocytes to commonly used mitogens. J Cell Physiol (1992) 0.92
Topical application of a protein kinase C inhibitor reduces skin and hair pigmentation. J Invest Dermatol (2004) 0.92
Signaling pathways mediating melanogenesis. Cell Mol Biol (Noisy-le-grand) (1999) 0.91
Loss of expression of protein kinase C beta is a common phenomenon in human malignant melanoma: a result of transformation or differentiation? Melanoma Res (2001) 0.87
Studies on the Cloudman melanoma cell line as a model for the action of MSH. Yale J Biol Med (1986) 0.87
Acute hyperglycemia regulates transcription and posttranscriptional stability of PKCbetaII mRNA in vascular smooth muscle cells. FASEB J (1999) 0.86
Microphthalmia transcription factor: a sensitive and specific marker for malignant melanoma in cytologic specimens. Cancer (2001) 0.86
Induction of protein kinase C in mouse melanoma cells by retinoic acid. Cancer Res (1989) 0.85
Induction of melanogenesis during the various melanoma growth phases and the role of tyrosinase, lysosome-associated membrane proteins, and p90 calnexin in the melanogenesis cascade. J Investig Dermatol Symp Proc (1996) 0.85
Alpha-melanocyte stimulating hormone-induced pigmentation is blocked by depletion of protein kinase C. Exp Cell Res (1996) 0.84
In B16 melanoma cells, the inhibition of melanogenesis by TPA results from PKC activation and diminution of microphthalmia binding to the M-box of the tyrosinase promoter. Oncogene (1998) 0.84
Microphthalmia-associated transcription factor and tyrosinase as markers of melanoma cells in blood of patients with melanoma. Croat Med J (2004) 0.80
Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma. J Invest Dermatol (2004) 3.80
miR-214 targets ATF4 to inhibit bone formation. Nat Med (2012) 3.01
A delivery system targeting bone formation surfaces to facilitate RNAi-based anabolic therapy. Nat Med (2012) 2.53
A call for the development and implementation of a targeted national melanoma screening program. Arch Dermatol (2006) 2.29
Academic dermatology manpower: issues of recruitment and retention. Arch Dermatol (2007) 2.02
Adipose tissue inflammation and adiponectin resistance in patients with advanced heart failure: correction after ventricular assist device implantation. Circ Heart Fail (2012) 1.79
Melanoma incidence and mortality among US whites, 1969-1999. JAMA (2002) 1.74
Mical links semaphorins to F-actin disassembly. Nature (2010) 1.74
Sunlight, tanning booths, and vitamin D. J Am Acad Dermatol (2005) 1.68
The vitamin D questions: how much do you need and how should you get it? J Am Acad Dermatol (2006) 1.66
The oligodendrocyte-specific G protein-coupled receptor GPR17 is a cell-intrinsic timer of myelination. Nat Neurosci (2009) 1.60
A crucial role for Olig2 in white matter astrocyte development. Development (2007) 1.60
Transcriptional network analysis identifies BACH1 as a master regulator of breast cancer bone metastasis. J Biol Chem (2012) 1.58
Ultraviolet-fluorescent tattoo location of cutaneous biopsy site. Dermatol Surg (2011) 1.51
Demonstration of functional coupling between gamma -aminobutyric acid (GABA) synthesis and vesicular GABA transport into synaptic vesicles. Proc Natl Acad Sci U S A (2003) 1.43
An oligodendrocyte-specific zinc-finger transcription regulator cooperates with Olig2 to promote oligodendrocyte differentiation. Development (2006) 1.43
Visual screening for malignant melanoma: a cost-effectiveness analysis. Arch Dermatol (2007) 1.41
Pitfalls of evidence-based medicine: the example of actinic keratosis therapy. Arch Dermatol (2012) 1.40
THE BIOLOGIC BASIS OF TRANSGENDER IDENTITY: 2D:4D FINGER LENGTH RATIOS IMPLICATE A ROLE FOR PRENATAL ANDROGEN ACTIVITY. Endocr Pract (2017) 1.39
Evidence that exposure of the telomere 3' overhang sequence induces senescence. Proc Natl Acad Sci U S A (2003) 1.37
Wnt and frizzled receptors as potential targets for immunotherapy in head and neck squamous cell carcinomas. Oncogene (2002) 1.37
Noggin overexpression inhibits eyelid opening by altering epidermal apoptosis and differentiation. EMBO J (2003) 1.27
Neoadjuvant modified (m) FOLFIRINOX for locally advanced unresectable (LAPC) and borderline resectable (BRPC) adenocarcinoma of the pancreas. Ann Surg Oncol (2014) 1.25
Modulation of BMP signaling by noggin is required for induction of the secondary (nontylotrich) hair follicles. J Invest Dermatol (2002) 1.25
Amyloid beta binds trimers as well as monomers of the 75-kDa neurotrophin receptor and activates receptor signaling. J Biol Chem (2001) 1.23
Telomere 3' overhang-specific DNA oligonucleotides induce autophagy in malignant glioma cells. FASEB J (2007) 1.22
Skin cancer prevention and detection practices among siblings of patients with melanoma. J Am Acad Dermatol (2003) 1.22
Telomere-based DNA damage responses: a new approach to melanoma. FASEB J (2004) 1.21
Transcriptional regulation of Arabidopsis MIR168a and argonaute1 homeostasis in abscisic acid and abiotic stress responses. Plant Physiol (2012) 1.19
Single-incision laparoscopic versus conventional laparoscopic right hemicolectomy: a comparison of short-term surgical results. Surg Endosc (2011) 1.17
p75 Neurotrophin receptor antagonist retards apoptosis-driven hair follicle involution (catagen). J Invest Dermatol (2003) 1.16
A trial of short incubation, broad-area photodynamic therapy for facial actinic keratoses and diffuse photodamage. Arch Dermatol (2004) 1.14
Improving skin cancer prevention and detection education in US medical schools. Arch Dermatol (2006) 1.14
Induction of apoptosis by telomere 3' overhang-specific DNA. Exp Cell Res (2002) 1.14
Unity in action. J Invest Dermatol (2014) 1.12
Bone morphogenetic protein (BMP) signaling controls hair pigmentation by means of cross-talk with the melanocortin receptor-1 pathway. Proc Natl Acad Sci U S A (2004) 1.10
Fifty years of skin aging. J Investig Dermatol Symp Proc (2002) 1.10
Telomere homolog oligonucleotides induce apoptosis in malignant but not in normal lymphoid cells: mechanism and therapeutic potential. Int J Cancer (2009) 1.08
Telomeric DNA induces apoptosis and senescence of human breast carcinoma cells. Breast Cancer Res (2007) 1.06
A randomized trial to improve early detection and prevention practices among siblings of melanoma patients. Cancer (2006) 1.05
Signaling pathway requirements for induction of senescence by telomere homolog oligonucleotides. Exp Cell Res (2004) 1.05
Relation of preoperative serum albumin levels to survival in patients undergoing left ventricular assist device implantation. Am J Cardiol (2013) 1.04
Topical DNA oligonucleotide therapy reduces UV-induced mutations and photocarcinogenesis in hairless mice. Proc Natl Acad Sci U S A (2004) 1.04
Induction of a p95/Nbs1-mediated S phase checkpoint by telomere 3' overhang specific DNA. FASEB J (2003) 1.04
A role for WRN in telomere-based DNA damage responses. Proc Natl Acad Sci U S A (2006) 1.03
Recent therapeutic advances in the treatment of colorectal cancer. Annu Rev Med (2014) 1.03
Genome update: distribution of two-component transduction systems in 250 bacterial genomes. Microbiology (2005) 1.02
A novel patient-derived intra-femoral xenograft model of bone metastatic prostate cancer that recapitulates mixed osteolytic and osteoblastic lesions. J Transl Med (2011) 1.00
The first 15 years of the American Academy of Dermatology skin cancer screening programs: 1985-1999. J Am Acad Dermatol (2003) 1.00
delta-Aminolevulinic acid and blue light photodynamic therapy for treatment of multiple basal cell carcinomas in two patients with nevoid basal cell carcinoma syndrome. Dermatol Surg (2004) 0.97
Fate of melanocytes during development of the hair follicle pigmentary unit. J Investig Dermatol Symp Proc (2003) 0.97
Protective function of taurine in glutamate-induced apoptosis in cultured neurons. J Neurosci Res (2009) 0.96
T-oligo treatment decreases constitutive and UVB-induced COX-2 levels through p53- and NFkappaB-dependent repression of the COX-2 promoter. J Biol Chem (2005) 0.96
Features that determine telomere homolog oligonucleotide-induced therapeutic DNA damage-like responses in cancer cells. J Cell Physiol (2007) 0.93
Topical application of a protein kinase C inhibitor reduces skin and hair pigmentation. J Invest Dermatol (2004) 0.92
DNA oligonucleotide treatment corrects the age-associated decline in DNA repair capacity. FASEB J (2002) 0.92
Topical thymidine dinucleotide treatment reduces development of ultraviolet-induced basal cell carcinoma in Ptch-1+/- mice. Am J Pathol (2008) 0.92
Mitogen-activated protein kinase mediates the apoptosis of highly metastatic human non-small cell lung cancer cells induced by isothiocyanates. Br J Nutr (2011) 0.92
Gene silencing of BAG-1 modulates apoptotic genes and sensitizes lung cancer cell lines to cisplatin-induced apoptosis. Cancer Biol Ther (2010) 0.91
Tumor-associated macrophage-derived IL-6 and IL-8 enhance invasive activity of LoVo cells induced by PRL-3 in a KCNN4 channel-dependent manner. BMC Cancer (2014) 0.91
Inhibition of microRNA-24 expression in liver prevents hepatic lipid accumulation and hyperlipidemia. Hepatology (2014) 0.91
Psychosocial aspects of aging skin. Dermatol Clin (2005) 0.91
Protein phosphorylation of human brain glutamic acid decarboxylase (GAD)65 and GAD67 and its physiological implications. Biochemistry (2004) 0.90
Comparison of microsomal prostaglandin E synthase-1 deletion and COX-2 inhibition in acute cardiac ischemia in mice. Prostaglandins Other Lipid Mediat (2009) 0.90
The year of unity. J Invest Dermatol (2013) 0.90
Quantification of inducible SOS-like photoprotective responses in human skin. J Invest Dermatol (2007) 0.89
Cloning and functional analysis of FLJ20420: a novel transcription factor for the BAG-1 promoter. PLoS One (2012) 0.89
Clinicopathological features and prognosis of gastroenteropancreatic neuroendocrine tumors: analysis from a single-institution. Asian Pac J Cancer Prev (2013) 0.88
Laparoscopic anterior approach of major hepatectomy combined with colorectal resection for synchronous colorectal liver metastases. Surg Laparosc Endosc Percutan Tech (2014) 0.88
Prognostic significance of neuroendocrine differentiation in colorectal adenocarcinoma after radical operation: a meta-analysis. J Gastrointest Surg (2014) 0.87
PRL-3 promotes the proliferation of LoVo cells via the upregulation of KCNN4 channels. Oncol Rep (2011) 0.87
Endoscopic treatments for Barrett's esophagus: a systematic review of safety and effectiveness compared to esophagectomy. BMC Gastroenterol (2010) 0.86
T-oligos augment UV-induced protective responses in human skin. FASEB J (2006) 0.86
The interdependence of skin aging, skin cancer, and DNA repair capacity: a novel perspective with therapeutic implications. Rejuvenation Res (2004) 0.85
Telomeric DNA induces p53-dependent reactive oxygen species and protects against oxidative damage. J Dermatol Sci (2009) 0.85
Tyrosinase gene expression is regulated by p53. J Invest Dermatol (2002) 0.85
Fas signaling is involved in the control of hair follicle response to chemotherapy. Cancer Res (2004) 0.85
KCNN4 channels participate in the EMT induced by PRL-3 in colorectal cancer. Med Oncol (2013) 0.85
Ventricular assist device implantation improves skeletal muscle function, oxidative capacity, and growth hormone/insulin-like growth factor-1 axis signaling in patients with advanced heart failure. J Cachexia Sarcopenia Muscle (2014) 0.84
The receptor for activated C-kinase-I (RACK-I) anchors activated PKC-beta on melanosomes. J Cell Sci (2004) 0.84
Modulations of nerve growth factor and Bcl-2 in ultraviolet-irradiated human epidermis. J Cutan Pathol (2003) 0.84
Modulation of vascular endothelial growth factor receptors in melanocytes. Exp Dermatol (2005) 0.84
Molecular cloning, expression, purification, and characterization of shorter forms of human glutamic decarboxylase 67 in an E. coli expression system. Brain Res Mol Brain Res (2005) 0.84
Butyrate interferes with the differentiation and function of human monocyte-derived dendritic cells. Cell Immunol (2012) 0.83
Bone morphogenetic protein-4, a novel modulator of melanogenesis. J Biol Chem (2006) 0.83
Fas and c-kit are involved in the control of hair follicle melanocyte apoptosis and migration in chemotherapy-induced hair loss. J Invest Dermatol (2003) 0.83
Should the skin cancer examination be taught in medical school? Arch Dermatol (2002) 0.83
More on MITF. J Invest Dermatol (2002) 0.82
Broad area photodynamic therapy for treatment of multiple basal cell carcinomas in a patient with nevoid basal cell carcinoma syndrome. J Drugs Dermatol (2006) 0.82
UV induces VEGF through a TNF-alpha independent pathway. FASEB J (2003) 0.82
Role of mu-calpain in proteolytic cleavage of brain L-glutamic acid decarboxylase. Brain Res (2008) 0.82
Skin cancer examination teaching in US medical education. Arch Dermatol (2006) 0.81
Topical application of thymidine dinucleotide to newborn mice reduces and delays development of UV-induced melanomas. J Invest Dermatol (2012) 0.81
Inhibition of the elicitation phase of contact hypersensitivity by thymidine dinucleotides is in part mediated by increased expression of interleukin-10 in human keratinocytes. Exp Dermatol (2003) 0.81
Inhibition of melanoma angiogenesis by telomere homolog oligonucleotides. J Oncol (2010) 0.81
Laparoscopic excision is an alterative method for rectal gastrointestinal stromal tumor. Surg Laparosc Endosc Percutan Tech (2010) 0.81
Photoprotection in human skin--a multifaceted SOS response. Photochem Photobiol (2008) 0.81